Mohammad H. Al‐Shaer

Author

Also Known As

Al-Shaer, Mohammad H., M Alshaer, M. Alshaer, M. H. Alshaer, M. H. Al‐Shaer, Mohammad H. Alshaer, Mohammad Al-Shaer, Mohammad Alshaer, Mohammad H Al-Shaer, Mohammad H Alshaer

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

University of Florida National Center for Tuberculosis and Lung Disease Emory University King Khalid University UF Health Shands Hospital

About

Mohammad H. Al‐Shaer is an author at University of Florida specializing in clinical epidemiology, antimicrobial resistance, and sepsis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	45
2	Clinical Epidemiology	1	1	45
3	Clinical Microbiology	1	1	45
4	Antimicrobial Resistance	1	1	45
5	Infection Control	1	1	45

Mohammad H. Al‐Shaer

Publications

786

Citations

H-Index

Page 1

	Year	Citations
International consensus recommendations for the use of prolonged‐infusion beta‐lactam antibiotics: Endorsed by the American College of Clinical Pharmacy, British Society for Antimicrobial Chemotherapy, Cystic Fibrosis Foundation, European Society of Clinical Microbiology and Infectious Diseases, Infectious Diseases Society of America, Society of Critical Care Medicine, and Society of Infectious Diseases Pharmacists Lisa Hong, Kevin J. Downes, Alireza FakhriRavari, Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy	2023	84
Early therapeutic monitoring of β-lactams and associated therapy outcomes in critically ill patients Mohammad H. Al‐Shaer, Eric Rubido, Kartikeya Cherabuddi, Journal of Antimicrobial Chemotherapy	2020	81
Protein Binding of First-Line Antituberculosis Drugs Wael A. Alghamdi, Mohammad H. Al‐Shaer, Charles A. Peloquin Antimicrobial Agents and Chemotherapy	2018	64
Meropenem, Cefepime, and Piperacillin Protein Binding in Patient Samples Mohammad H. Al‐Shaer, Wael A. Alghamdi, Emily Graham, Therapeutic Drug Monitoring	2019	54
Perspectives for personalized therapy for patients with multidrug‐resistant tuberculosis Christoph Lange, Wael A. Alghamdi, Mohammad H. Al‐Shaer, Journal of Internal Medicine	2018	45
Beta-lactam target attainment and associated outcomes in patients with bloodstream infections Mohammad H. Al‐Shaer, Nicole Maranchick, Kaitlin Alexander, International Journal of Antimicrobial Agents Healthcare-associated InfectionClinical EpidemiologyBloodstream InfectionsSepsisBeta-lactam Target Attainment	2023	45
Population Pharmacokinetics of Linezolid in Tuberculosis Patients: Dosing Regimen Simulation and Target Attainment Analysis Wael A. Alghamdi, Mohammad H. Al‐Shaer, Guohua An, Antimicrobial Agents and Chemotherapy	2020	42
Cycloserine and Linezolid for Tuberculosis Meningitis: Pharmacokinetic Evidence of Potential Usefulness Russell R. Kempker, Alison Smith, Teona Avaliani, Clinical Infectious Diseases	2021	40
Cycloserine Population Pharmacokinetics and Pharmacodynamics in Patients with Tuberculosis Wael A. Alghamdi, Abdullah Alsultan, Mohammad H. Al‐Shaer, Antimicrobial Agents and Chemotherapy	2019	39
Using Machine Learning To Define the Impact of Beta-Lactam Early and Cumulative Target Attainment on Outcomes in Intensive Care Unit Patients with Hospital-Acquired and Ventilator-Associated Pneumonia Mohammad H. Al‐Shaer, Nicole Maranchick, Kelly Maguigan, Antimicrobial Agents and Chemotherapy	2022	36

Page 1